Medications in Custody: Continuity, Formulary Substitution and Administration Records

Scope and warning#

This page addresses the medication system in jails and, by comparison, state prisons: verification and continuation of medications a person was taking before custody; formulary substitution and non-formulary requests; ordering, renewal and expiration; dispensing, administration and delivery; the medication administration record; keep-on-person (self-administered) versus directly observed medication; refusals; psychotropic medications and consent; medications for opioid use disorder at the level of disability law; and release supplies. It treats insulin, anticonvulsants, HIV antiretrovirals and psychotropics as illustrations, not as clinical guidance. It does not give medical advice about any drug, dose or substitution, and nothing here should be used to judge whether a particular medication decision was clinically correct; that is a question for qualified clinicians and experts.

Related subjects are elsewhere: intake screening (Roadmap 055); transfers and hospital returns (Roadmap 054); chronic disease management (Roadmap 057); withdrawal and medications for opioid use disorder in depth (Roadmaps 060, 061); mental-health care (Roadmap 062); refusal, informed consent and involuntary medication (Roadmap 072); the federal standards in full (Roadmaps 042, 043); and entity liability (Roadmaps 046 through 049). Title 15 sections were checked against Cornell LII/Justia reproductions and statutes against California.Public.Law or a mirrored enrolled bill. The current official BSCC Title 15 compilation and current California Legislative Information codification were not authenticated in this review; reproduced text must be rechecked before public/legal reliance. This page is not legal advice, and nothing on it authorizes any person to enter, search or copy from any jail, pharmacy or contractor system. It uses role vocabulary (patient, detainee, prisoner, personal representative, successor in interest, heir) rather than describing who is legally entitled to sue; Roadmaps 065 and 078 address which person may bring which claim.

The factual situation this roadmap addresses#

A generic hypothetical. A 37-year-old man is booked into a county jail on a pretrial hold. He has epilepsy controlled for years on a brand-name extended-release anticonvulsant, and HIV controlled on a single-tablet antiretroviral regimen. He brings both bottles; they are logged into property. The receiving screening records both medications. Verification with his community pharmacy is completed on the third day. The jail formulary does not stock his anticonvulsant formulation; a provider orders an immediate-release form of a different anticonvulsant at what the order describes as an equivalent dose, and orders the antiretroviral components as separate tablets from the formulary. The medication administration record for days one to three shows no entries for either condition; that documentary gap must be tested against actual orders, pharmacy/dispensing records, paper back-up records and patient observations before inferring that no dose was given. From day four it shows the new orders, with several evening doses marked "not available" and two morning doses marked "refused" with no refusal form. On day nine he has a generalized seizure in his cell, falls and fractures his jaw. A blood test the following week shows a subtherapeutic anticonvulsant level. His viral load, measured a month later, has risen.

The hypothetical is invented. It is built to raise each question this page addresses: the interval before verification; the substitution of a drug and a formulation; the "not available" entries; the undocumented refusals; the relationship between missed doses and the seizure; and the separate question whether interruptions of antiretroviral therapy caused a cognizable injury. It describes no real person, facility, pharmacy or contractor.

Governing law#

Title 15's pharmaceutical-management standard

Section 1216 requires that "The health authority in consultation with a pharmacist and the facility administrator, shall develop written plans, establish procedures, and provide space and accessories for the secure storage, the controlled administration, and disposal of all legally obtained drugs." The plans must include, among other things, "procedures for administration/delivery of medicines to incarcerated persons as prescribed;" procedures for "confirming that the recipient has ingested the medication"; a required record of whether prescribed medications have or have not been administered, by whom, and if not, for what reason; "prohibiting the delivery of drugs by incarcerated people;" a "limitation to the length of time medication may be administered without further medical evaluation;" and a "limitation to the length of time required for a physician's signature on verbal orders" (15 Cal. Code Regs. § 1216(a); AR-056-S01). A pharmacist must report on pharmacy services at least annually. Source grade: inspected 2023-amended text on Cornell LII, not an authenticated October 2026 BSCC codification. The duty to establish procedures is not itself proof of what a facility actually administered or documented.

Subdivision (b) allocates functions "consistent with pharmacy laws and regulations": "Procurement shall be done by a physician, dentist, pharmacist, or other persons authorized by law"; repackaging is similarly limited; labels must be checked by a physician, dentist or pharmacist and must conform to Business and Professions Code § 4076; "Dispensing shall only be done by a physician, dentist, pharmacist, or persons authorized by law"; "Administration of medication shall only be done by licensed health personnel" acting on a prescriber's order; and "Delivery of medication may be done by either licensed or non-licensed personnel, e.g., custody staff," acting on a prescriber's order. Disposal follows pharmacy law and, for controlled substances, federal procedures (AR-056-S01). The reproduced §1216(b)(2) additionally distinguishes limited access to stock legend drugs by licensed health personnel from access to dispensed legend or over-the-counter supplies; delivery by nonlicensed custody personnel under (b)(7) is not permission to perform the licensed clinical act of administration under (b)(6). Subdivision (c) requires policies for over-the-counter medications and precautions against hoarding.

Subdivision (d) permits self-administration (keep-on-person medication) only within limits: "Policy and procedures may allow self-administration of prescribed medications under limited circumstances," limited to medications "with no recognized abuse potential," and "Medications for treatment of tuberculosis, psychotropic medication, controlled substances, injectables and any medications for which documentation of ingestion is essential are excluded from self-administration." Participants must understand the program's rules, medications must be secured when not on the person, custody and health staff must enforce and communicate, and health staff must perform documented compliance assessments often enough to prevent hoarding and health decline (AR-056-S01). Source grade: reproduced text; current official promulgated version not independently authenticated. A self-administration assessment is not equivalent to witnessing each dose.

Three other Title 15 provisions frame the record. The health record must include the "names of personnel who treat, prescribe, and/or administer/deliver prescription medication;" and the medication records required by § 1216 (§ 1205(a); AR-054-S07). The procedures manual must address the handling of pharmaceuticals from procurement to disposal (§ 1206(j); AR-054-S08). And care by non-physician personnel must follow written protocol or order (§ 1204; AR-031-R03), which is why nursing medication protocols, pre-authorized nursing orders and bridge orders are documents to request. Crucially, §1206(n) separately calls for the transfer of pertinent individualized health information when a person moves to another correctional system, medical or mental-health facility: the summary is to identify prescribed medications, needed follow-up, pending appointments and significant problems, with necessary medication and health information communicated to transport staff. Whether a particular medication was supplied, handed off or omitted requires the actual transfer packet, timestamps and receiving-facility record (source grade: reproduced regulatory text, official current codification pending).

The reproduction host's summary notes that § 1216 does not expressly address the continuation of medications brought in at booking or the verification of outside prescriptions; those subjects are typically governed by the facility's written procedures under § 1216(a), the screening and referral plans under §§ 1207 and 1208 (AR-055-S01, AR-055-S09), and the individualized treatment plan under § 1210 (AR-054-S10) (Analytical inference). Title 15 is a minimum standard; whether a deviation supports negligence per se or is evidence of the standard of care is a counsel question (Roadmap 088).

Psychotropic medications, consent and involuntary medication

Section 1217 requires the responsible physician to "develop written policies and procedures governing the use of psychotropic medications." A person "may be involuntarily given psychotropic medication appropriate to the illness on an emergency basis" when judged a danger to self or others; "It is not necessary for harm to take place prior to treatment," but the medication "shall be only that which is required to treat the emergency condition." Outside an emergency, psychotropic medication "shall not be administered to an incarcerated person absent an emergency" without informed consent under the Welfare and Institutions Code or a lawful capacity determination. "The medication shall be prescribed by a physician following a clinical evaluation"; the policy must include a protocol that "limits the length of time both voluntary and involuntary psychotropic medications may be administered" with monitoring and re-evaluation; and "The administration of psychotropic medication is not allowed for disciplinary reasons" (15 Cal. Code Regs. § 1217; AR-056-S02). Source grade: inspected 2023-amended regulatory reproduction, not authenticated current official Title 15; the facility's emergency criteria and applicable judicial orders require a fact-specific examination.

Section 1214 requires "a plan for informed consent of incarcerated persons in a language understood by the incarcerated person," applies to "all examinations, treatments and procedures affected by informed consent standards in the community," provides that a person not adjudicated incompetent "may refuse non-emergency medical and mental health care," and states that, absent informed consent in a non-emergency, "a court order is required before involuntary medical treatment can be administered" (AR-056-S03). Penal Code § 2603 governs involuntary psychiatric medication of county jail inmates (defined to include sentenced inmates, persons awaiting or undergoing trial, and persons awaiting arraignment): an inmate "shall not be administered any psychiatric medication without their prior informed consent," except through the emergency procedure or after a hearing at which the decision-maker finds by "clear and convincing evidence that the inmate has a mental illness or disorder," with the other statutory findings; the county must document "a documented attempt to locate an available bed for the inmate in a noncarceral treatment facility"; and the section states that it "shall remain in effect only until January 1, 2030" (AR-056-S06). Grade: Settled (statutory text; reproduction host). Effective in 2026, Penal Code §2603.5 (2025 SB 820, ch. 330) establishes a separate, narrow rule for certain persons found incompetent to stand trial on a misdemeanor and confined in county jail; it concerns involuntary antipsychotic medication, with defined emergency and court-hearing procedures, required consideration of community treatment beds, monitoring in specified circumstances, and review and duration limits. It does not apply to every patient on psychotropics or replace the ordinary informed-consent analysis. Section 2603.5 is inspected through a statutory reproduction and mirrored enrolled bill, not an authenticated live official codification. Roadmap 072 addresses these procedures in full.

For the medication-continuity question, these rules have a practical consequence. Psychotropics are excluded from §1216(d) self-administration; this does not mean the regulation proves that every scheduled dose was actually swallowed under direct observation. Section 1216(a) separately addresses confirmation of ingestion and documentation of doses given or not given. For a charted refusal, check the order, consent status, any refusal or counseling note, facility policy and whether emergency or court-ordered procedures applied; §1216(a)(5) does not itself require a separate refusal form in every instance (Analytical inference).

Pharmacy law and controlled-substance rules at description level

Title 15 incorporates pharmacy law rather than restating it. Business and Professions Code § 4076 provides that "A pharmacist shall not dispense a prescription except in a container" labeled with, among other things, "The name of the patient or patients," "The directions for the use of the drug," the prescriber, the drug name and strength, and "The expiration date of the effectiveness of the drug dispensed" (AR-056-S04). The Pharmacy Law's article on correctional clinics defines a "Correctional clinic" as a primary care clinic "conducted, maintained, or operated by the state to provide health care to eligible patients of the Department of Corrections and Rehabilitation" (Bus. & Prof. Code § 4187; AR-056-S05); on the text read, that article concerns state prisons, not county jails, whose pharmacy arrangements are governed by general pharmacy law, Title 15 and the facility's contracts (Analytical inference; counsel to confirm). Grade: Settled as text (reproduction host); the remainder of the Pharmacy Law is described, not opened.

Federal controlled-substance rules shape medications for opioid use disorder. Section 1306.07 draws schedule- and activity-specific boundaries. Subsection (a) limits direct administration/dispensing (not prescribing) of a Schedule II narcotic for maintenance or detoxification to a separately registered narcotic treatment program meeting regulatory conditions; subsection (b) allows a qualifying non-program practitioner, consistent with other law, to dispense but not prescribe up to a three-day supply at one time as nonrenewable emergency initiation/bridge treatment while arranging referral; subsection (c) preserves specified incidental hospital treatment; and subsection (d) separately addresses Schedule III–V narcotics, including prescribing. The 2026 reproduced §1306.07 also contains a narrower pharmacy-to-practitioner injection/implantation pathway in (f). None of these alone proves a jail had a particular drug, registration, staff authority or compliant distribution process. Source grade: current Cornell LII reproduction reflecting 2026 amendments, not direct authenticated eCFR text (official eCFR open failed). Roadmap 061 addresses how jails continue methadone and buprenorphine.

The constitutional standards applied to medications

The general standards are those of Roadmaps 042 and 043: for detainees, the objective four-element test of Gordon v. County of Orange (AR-0961-C01); for prisoners, deliberate indifference under Estelle and Farmer (AR-0961-C02, AR-0961-C03). Within those standards, several Ninth Circuit decisions address medications specifically.

Interference with treatment. Indifference "may appear when prison officials deny, delay or intentionally interfere with medical treatment" (Jett v. Penner, 439 F.3d 1091 (9th Cir. 2006); AR-C31). A medication that has been prescribed and is not delivered is the paradigm of a possible delay or interference; the question is whose decision, if any, caused the interruption and what that person knew (Analytical inference).

Insulin and diabetes. In Lolli v. County of Orange, 351 F.3d 410 (9th Cir. 2003) (AR-051-C02), on the plaintiff's evidence as the opinion describes it, an insulin-dependent detainee told the arresting officer and the screening nurse that he was diabetic, felt ill and needed to eat, and was held for hours without food or insulin; officers disputed what they had been told. The court held that "Diabetes is a common yet serious illness" and "It constitutes a serious medical need," that "Leaving a diabetic such as Lolli without proper food or insulin when it is needed creates an" objectively serious risk, and that, on the plaintiff's evidence including "his explicit statements that he needed food because he was a diabetic," a jury could find that certain officers "knew of Lolli's diabetic condition and need for food" and disregarded it. On the medical-needs claim it affirmed summary judgment for the sheriff, the assistant sheriff and one sergeant, reversed it as to another sergeant, and affirmed summary judgment for the county on the entity claim. A reversal of summary judgment is not a finding that any officer acted unlawfully. Grade: Settled in the Ninth Circuit as to diabetes as a serious medical need; the knowledge holding is record-specific (Analytical inference as to other facts). Lolli was decided under the subjective standard before Castro and Gordon (Roadmap 055).

Substitution and difference of opinion. In Toguchi v. Chung, 391 F.3d 1051 (9th Cir. 2004) (AR-C32, opened this session), a prison psychiatrist discontinued one antipsychotic regimen and prescribed another; the patient later died of combined drug toxicity. The court affirmed summary judgment, holding that a "difference of medical opinion [is] insufficient, as a matter of law, to establish deliberate indifference," that a plaintiff challenging a choice between treatments must show the course chosen "was medically unacceptable under the circumstances," and chosen "in conscious disregard of an excessive risk" to health, that "Deliberate indifference is a high legal standard," and that "Mere negligence in diagnosing or treating a medical condition, without more, does not violate a prisoner's Eighth Amendment rights." It rejected a theory that the withdrawal of another drug had been ignored because "There is absolutely no indication in the record that [the psychiatrist] was aware of a risk." Hamby v. Hammond, 821 F.3d 1085 (9th Cir. 2016) (AR-052-C03) applied the same rule to a review committee's choice of conservative treatment over surgery, described the record as showing at most "a difference of medical opinion," and resolved the case on qualified immunity because it was "at least debatable that the prison officials here complied with the Eighth Amendment"; a partial dissent stated that "a difference of medical opinion does not preclude a finding of deliberate indifference" where a denial may have been policy-driven rather than individualized. Grade: Settled in the Ninth Circuit (Toguchi); Majority/likely (Hamby's application).

Blanket policies versus individualized judgment. Colwell v. Bannister, 763 F.3d 1060 (9th Cir. 2014) (AR-052-C01) reversed summary judgment where a prison system allegedly denied cataract surgery under a "one eye" practice despite treating specialists' recommendations; the court described a "blanket, categorical denial of medically indicated surgery solely on the basis of an administrative policy" and stated: "This is the very definition of deliberate indifference." Snow v. McDaniel (AR-052-C02) found a triable question where non-examining reviewers overrode treating recommendations without a medical reason and there was evidence of cost-related motive. The en banc court in Peralta v. Dillard, 744 F.3d 1076 (9th Cir. 2014) (AR-C47, opened this session), held that in a damages action against an individual official who lacks authority over budgeting decisions "What resources were available is highly relevant," overruled Snow and an earlier case in part ("To the extent Jones and Snow can be read to apply to monetary damages against an official who lacks authority over budgeting decisions, they are overruled"), and distinguished prospective relief: "Lack of resources is not a defense to a claim for prospective relief." Grade: Settled in the Ninth Circuit (Colwell; Peralta); the analogy from surgical-policy cases to formulary rules is Analytical inference.

Policy deviations and protocols. The comment to the Ninth Circuit's model instruction describes Russell v. Lumitap, 31 F.4th 729 (9th Cir. 2022) as holding that there is "no § 1983 liability for simply acting contrary to prison policy," while noting that standardized procedures can show that officials had facts indicating a serious medical risk (AR-055-G01; Russell not opened; description level). A missed dose that violates a medication policy is not, by that fact, a constitutional violation; the policy may nonetheless show what the defendant knew (Analytical inference).

Release supplies. A state "must provide an outgoing prisoner who is receiving and continues to require medication" with a supply sufficient for "the period of time reasonably necessary to permit him to consult a doctor and obtain a new supply" (Wakefield v. Thompson, AR-053-C01; Roadmap 054). Grade: Settled in the Ninth Circuit; application to county-jail release is Analytical inference.

Disability law and medications for opioid use disorder

ADA Title II forbids a public entity to exclude or discriminate against a qualified individual "by reason of such disability" (42 U.S.C. § 12132; AR-S937), and its jail regulation reaches facilities operated "through contractual, licensing, or other arrangements with public or private entities" (28 C.F.R. § 35.152(a); AR-055-R01). The Ninth Circuit has held that "The ADA prohibits discrimination because of disability, not inadequate treatment for disability" (Simmons v. Navajo County; AR-063-C05). **But the published September 8, 2026 Adom v. CDCR opinion** explains that Simmons does not categorically remove medical-provider decisions from ADA scrutiny: a disabled prisoner seeking access to prison toileting/hygiene services through incontinence supplies raised a triable reasonable-accommodation claim even though clinicians had questioned medical necessity. Adom concerned disability-related program access, not a holding that every disputed medication selection or delayed prescription violates Title II. The published official Ninth Circuit PDF was inspected, including its discussion at page 32; full later case history remains unchecked. The Department of Justice's guidance on opioid use disorder takes the position that a person using medication for opioid use disorder under a licensed professional's supervision is not engaged in illegal drug use, and gives the example: "A jail does not allow incoming inmates to continue taking MOUD prescribed before their detention," concluding that "The jail's blanket policy prohibiting the use of MOUD would violate the ADA" (U.S. Department of Justice, The ADA and Opioid Use Disorder (Apr. 5, 2022); AR-056-G01, ada.gov). Grade: Documented report (agency guidance; the page itself states it is informal and not binding). After Adom, the analysis cannot stop with a label of medical treatment or with the presence of a physician: ask whether the challenged blanket rule denies disability-related access or reasonable accommodation, whether the requested medication is a clinical treatment decision instead, and whether safety/medical distinctions are evidenced rather than assumed. This is a fact-specific analogy, **not an Adom MOUD holding**; the 2022 DOJ guidance remains nonbinding. Roadmaps 061 and 068 address MOUD in depth.

California tort law: § 845.6 and professional negligence

Medication cases test the boundary drawn in Roadmap 054. Government Code § 845.6 makes an employee and entity liable where the employee "knows or has reason to know that the prisoner is in need of immediate medical care and he fails to take reasonable action to summon such medical care" (AR-051-S01). The California Court of Appeal has held that the statute covers the failure to summon care, not "malpractice in furnishing or obtaining that medical care," and that "Once summoned, the quality of medical care is a matter of medical policy and practice" (Castaneda; AR-054-C01). A missed or substituted dose is usually a furnishing/quality-of-care issue, not automatically a §845.6 failure-to-summon claim. A distinct, recognized need for immediate care, an employee's actual or constructive knowledge, a failure to take reasonable action to summon care and legally adequate causation must each be proved to fit the narrower statute. Emergency symptoms can raise that question but do not establish all elements (Analytical inference from §845.6 and Castaneda). Lawson v. Superior Court (2010) 180 Cal.App.4th 1372 is frequently cited on § 845.6 in a diabetic-detainee setting and was not opened (description level). The entity's general immunity for injury to a prisoner does not exonerate employees, and the entity pays healing-arts malpractice judgments against its employees (Gov. Code § 844.6(d); AR-051-S02); public employees are otherwise liable as private persons would be (Gov. Code § 820; AR-051-S06). Professional negligence against a prescriber, nurse or pharmacist, and against a private contractor, follows Roadmap 066.

The medication administration record: how to read it#

The medication administration record is the central document in a medication case because § 1216(a) requires it to show "that prescribed medications have or have not been administered, by whom, and if not, for what reason." Read it with the order record and the pharmacy record side by side, and in this sequence.

First, establish the orders. For each medication, identify the order date and time, the prescriber, the drug, formulation, dose, route, frequency and stop date, and any verbal or telephone order with the time it was signed (the § 1216(a)(8) limit). Note the order's expiration: § 1216(a)(7) requires a limit on how long medication may be given without further evaluation, so an order that expired without renewal may explain a scheduled-dose gap, but an empty MAR cell does not establish why the entry is missing; check order audit, renewal attempts and whether care continued on a valid replacement order.

Second, map each scheduled dose. A twice-daily order produces two expected entries per day. For each expected dose there should be an entry: given (with the initials or signature of the person who administered or delivered, and for directly observed medications confirmation of ingestion under § 1216(a)(4)), not given with a reason, refused, or held on a prescriber's instruction. Blanks raise a documentation and preservation question; they are not by themselves proof that a scheduled dose was withheld, that the person named in the MAR knew, or that the omission caused injury. Check paper downtime charts, audit logs, correction entries and verification against dispensing and custody records.

Third, read the reasons. Entries such as "not available," "not in stock," "patient at court," "lockdown," "housing unit not accessible," "pending pharmacy," "refused," or "asleep" each point to a different system: pharmacy supply, custody movement, staffing, or the patient. A refusal should be evaluated against contemporaneous notes, capacity and communication needs, any applicable consent/counseling policy, and whether reasonable follow-up was attempted for high-risk medication. Section 1216(a)(5) does not prescribe a universal standalone refusal-form requirement. A bare "refused" code without a source, patient response or timestamp has limited evidentiary weight but does not itself disprove refusal.

Fourth, compare with the pharmacy record. Dispensing logs, delivery manifests from any outside pharmacy, stock counts and non-formulary request logs show whether a drug was in the building when the record says it was "not available." Fifth, compare with the clinical record: drug levels (for anticonvulsants, lithium and some other drugs), glucose logs, viral loads, symptoms reported on sick-call slips, and the events the medication was meant to prevent. Sixth, compare with custody records: movement logs, court-transport records, lockdown logs, and housing assignments, which explain or contradict the reasons given.

The result is a table, one row per scheduled dose, showing ordered, given, missed (with reason) or refused, the person responsible, and the corroborating record. That table, kept on Worksheet 109, is what an expert uses to connect doses to outcomes.

Formulary substitution: when a change is clinical judgment and when it is a gap#

A formulary is a list of drugs a pharmacy keeps in stock, chosen for clinical, supply and cost reasons. Community hospitals and health plans use them; so do jails and prisons. Substitution of a formulary drug for a patient's community drug is common and often appropriate. The legal question is not whether a substitution occurred but how.

A substitution that reflects clinical judgment typically has these features in the record: a prescriber's documented review of the patient's prior regimen; a stated reason for the change; attention to the specific risks of switching for this patient (for an anticonvulsant, the formulation and the risk of breakthrough seizures; for an antiretroviral regimen, the risk of incomplete or interrupted therapy; for a psychotropic, the history of response); a plan for monitoring (levels, symptoms, follow-up); and, where the formulary drug is not appropriate, a non-formulary request and a timely decision. Such documentation may help defeat an inference of unconstitutional indifference under Toguchi and Hamby, but it is not a safe harbor: objective Fourteenth Amendment duties for pretrial detainees, medication-specific risk, implementation, actual supply, and negligence standards remain separate questions.

A substitution that reflects a gap looks different: no documented review; an automatic interchange applied by a protocol without a prescriber's consideration of the patient; a non-formulary request that was not made, not acted on, or denied without a medical reason; no monitoring; or an interruption between the old drug and the new one. Colwell's description of a "blanket, categorical denial" solely on the basis of an administrative policy, and Snow's attention to unexplained overrides of treating recommendations, are the analogies plaintiffs will draw; Peralta's holding that available resources are "highly relevant" to the damages liability of an individual official without budgeting authority, and Hamby's treatment of conservative choices, are the analogies defendants will draw (Analytical inference throughout). In practice the documents that decide the question are the formulary itself and its version history, the non-formulary request process and its logs, any therapeutic-interchange protocol, and the prescriber's note.

Applying the law to the hypothetical#

The man was a pretrial detainee, so the objective Gordon standard governs any federal claim against an individual (Roadmap 041). The first interval, days one to three, has no entries for either condition. The question is whether that interval reflects a decision (for example, a prescriber's decision to wait for verification rather than to order a bridge dose of a medication with a known seizure risk) or the absence of any decision. If the screening recorded both medications and the facility's written procedure called for clinician notification and bridge orders, the gap points toward the routing of screening information (Roadmap 055); if no procedure existed, toward the procedure's design (Roadmaps 047, 048).

The substitution on day four was made by a prescriber with an order describing equivalence. Under Toguchi and Hamby, a documented choice of a formulary anticonvulsant is likely to be treated as medical judgment unless an expert can show that the change of drug and formulation was medically unacceptable for this patient and that the prescriber disregarded a known risk. If the note shows no consideration of the patient's seizure history and no non-formulary request, the argument changes. The "not available" entries are a separate issue: they suggest a supply failure, which, if it recurred across patients, could be a subject of entity inquiry, and, for this patient, is a delay in prescribed treatment of the kind Jett describes. The two "refused" entries without forms weaken any defense based on refusal for those doses but do not establish what happened.

The seizure, the jaw fracture and the subtherapeutic level present a causation question for experts (Roadmap 075). The rising viral load presents a harder damages question: whether the interruption caused a physical injury, an increased risk, or neither. Under California law, the medication decisions are likely professional-negligence questions rather than § 845.6 questions (Castaneda), but the response to the seizure itself, whether care was summoned promptly, is squarely within § 845.6. None of this states what any record would show.

A step-by-step approach#

1. List every medication the person was taking before custody, with prescriber, pharmacy, dose and the condition treated; gather any bottles, pharmacy printouts and prescriptions lawfully in the family's possession (Worksheet 109).
2. Request the patient's own jail health record, including the medication administration record, order sheets, refusal forms and laboratory results, under Health & Safety Code § 123110 (AR-S401), or through the personal representative (Model 132; Roadmap 083).
3. Build the dose-by-dose table described above for each medication of concern.
4. Mark each gap as no order, order expired, not available, custody reason, refused, or blank, and note the corroborating record for each.
5. Identify each substitution and whether the record shows a prescriber's review, a reason, a non-formulary request and a monitoring plan.
6. Send preservation demands for pharmacy dispensing records, stock and delivery records, non-formulary request logs, the formulary and its history, and the electronic record's audit trail (Roadmap 007; Model 132).
7. Where the person remains in custody, use the medical-request and grievance processes in writing and keep copies; for an urgent interruption, counsel may seek court relief (Roadmap 080).
8. Identify every public entity for claim presentation and every health care provider for § 364 notice (Roadmaps 066, 078; Model 131).
9. Obtain an expert review connecting specific missed or changed doses to specific consequences (Roadmaps 074, 075).
10. Take the table, the records and the expert's preliminary view to counsel before drafting any pleading. Do not allege a fact unless you have a good-faith factual basis for it.

Elements of the claim#

Fourteenth Amendment (pretrial detainee), against an individual: the four Gordon elements (AR-0961-C01); the "intentional decision" may concern an identifiable clinician's order, omission to act where action was required, substitution or response to a known supply problem; mere institution-wide computer failure or unexplained record blank does not identify a defendant's intentional decision. The remaining Gordon elements, objectively unreasonable failure to take available measures and causation, must still be supported. Eighth Amendment (sentenced prisoner): serious medical need and deliberate indifference (AR-0961-C02, AR-0961-C03), with the Toguchi requirements where a treatment choice is challenged (AR-C32). Entity liability under § 1983: the county's or contractor's own policy or custom as the moving force (Tsao, AR-0961-C08; Roadmap 047), for example a formulary or interchange practice applied without individualized review, or a recurring supply failure; a contracted clinician acts under color of state law (West v. Atkins, AR-0961-C07).

Government Code § 845.6: knowledge or reason to know of a need for immediate medical care and failure to take reasonable action to summon it (AR-051-S01, read with Castaneda). Professional negligence (description level; Roadmap 066): duty, breach of the standard of care by a prescriber, nurse or pharmacist, causation and damages. ADA Title II (Roadmap 068): discrimination by reason of disability, distinguished from inadequate treatment (Simmons). Pleading carries consequences under Code Civ. Proc. § 128.7 and Fed. R. Civ. P. 11 (AR-0961-S04; AR-0961-F02). Do not allege a fact unless you have a good-faith factual basis for it.

Potentially relevant defendants#

Described by role and function only. The prescriber who ordered, substituted, renewed or declined to renew; the nurse responsible for verification, bridge orders under protocol, and medication passes; the person who administered or delivered each dose, including custody staff delivering under § 1216(b)(7), to the extent their own conduct is in issue; the pharmacist or pharmacy responsible for supply, dispensing and non-formulary review, including any outside pharmacy under contract; the physician who established the medication protocols and formulary policies; supervisors, only for their own conduct (Roadmap 045); the county, through its own policy or custom and through the Government Claims Act; and any private health contractor or pharmacy vendor, through its own policy or custom (Roadmaps 046, 047). Identify each from orders, signatures, payroll and contracts, never from branding (Roadmaps 003, 004; Worksheet 101).

Administrative prerequisites#

Exhaustion: detainees and prisoners must exhaust available administrative remedies before a federal action about prison conditions (42 U.S.C. § 1997e(a), (h); AR-096-F04); a remedy that is a dead end or thwarted is unavailable (Ross v. Blake, AR-0961-C09). Medication interruptions are often continuing; a grievance about the interruption, filed while it is happening, also creates a record of notice (Roadmap 080). Government claims: within the § 911.2 period for death or personal injury, with the § 910 contents, before suit (AR-096-S01, AR-096-S02, AR-131-S01; late-claim relief AR-S503). Notice of intent: Code Civ. Proc. §364(a) ordinarily calls for 90 days' pre-suit notice for covered health-care-provider professional-negligence claims, with the specific §364(d) limitations extension and §364(e) Doe exception. Section 365 provides that noncompliance does not invalidate court proceedings or affect jurisdiction, although attorney-disciplinary consequences may apply. This is separate from the Government Claims Act's jurisdiction/procedural prerequisites and must not be treated as a substitute for claim presentation (statutory reproductions; official codification not authenticated).

Limitation periods#

This table identifies sources and triggers; it computes no date for any person.

Evidence and records to obtain#

Records key: H presently has lawfully; R statutory request; D discovery or subpoena only; P potentially privileged or private; K someone else must preserve but need not produce voluntarily (Roadmap 007); X must not access, copy or remove.

• The person's community prescriptions, pharmacy printouts and bottles lawfully in the family's possession (H); the community pharmacy's dispensing history (R for the patient's own records).
• The person's own jail MAR, medication orders, telephone/verbal-order signatures, refusal documentation and any keep-on-person agreements or compliance checks (R, only to the extent the requester is legally authorized and Health & Saf. Code §123110 or other applicable access rules permit; D for audit trails and any withheld system metadata). A family member's relationship alone does not grant authority to receive confidential health records.
• Laboratory results: drug levels, glucose logs, viral loads and other monitoring (R).
• Sick-call slips and responses, grievances and appeals about medications (H for copies; R; K).
• Pharmacy dispensing logs, delivery manifests from outside pharmacies, stock counts, "not available" reports and backorder records (D; K).
• The formulary and its version history, the non-formulary request procedure and request logs, and any therapeutic-interchange protocol (D; county-held documents may be sought under the Public Records Act, AR-S801, subject to exemptions; Roadmap 087).
• Medication protocols, pre-authorized nursing orders and bridge-order procedures under §§ 1204 and 1216 (D).
• The pharmacist's annual report under § 1216(a)(9) (D; may be withheld as quality material in part; P to that extent).
• Custody movement, court-transport and lockdown logs for dates with "patient unavailable" entries (D; K).
• Contracts with any pharmacy vendor and the county health-services contract (R under the Public Records Act, subject to exemptions; Roadmaps 086, 087).
• Medication-error reports and quality reviews (P; Evid. Code § 1157, AR-032-S04, to the extent it applies; Roadmap 085).
• Other patients' medication records (P; obtainable, if at all, only in discovery under protective order).
• Pharmacy backend systems, staff-only eMAR and jail health-record systems (X: do not access without lawful individual access or explicit role-based authority). This does not prohibit a patient or authorized representative from requesting or lawfully receiving their own records; treat protected data about other patients, privilege, log credentials and privileged review material separately.

Favorable and adverse facts#

Facts that tend to support a claim: a medication known at intake with no bridge order or verification for days; a dangerous interruption for a condition such as epilepsy, insulin-dependent diabetes, HIV, serious mental illness or a recent clot; substitutions without a documented prescriber review or reason; non-formulary requests not made or not decided; repeated "not available" entries; blanks; refusals without forms; written requests or grievances about the medication; abnormal levels or measurable deterioration following the gap; and a pattern across patients suggesting a supply or policy cause.

Facts that tend to defeat a claim: prompt verification and bridge orders; documented prescriber review of any substitution with monitoring; adequate drug levels; refusals documented with explanation of risks; a condition that worsened for reasons unrelated to the medication; a gap too short to have clinical effect; the patient's own nonadherence before custody; and evidence that the facility made reasonable efforts to obtain a drug that was genuinely unavailable.

Likely defenses#

Roadmap 133 collects the defenses. In medication cases the most common are: medical judgment and difference of opinion (Toguchi; Hamby; Roadmap 044); no knowledge by the individual defendant of the gap or its risk; refusal by the patient (supported or not by forms); nonadherence or concealment; lack of available resources, relevant under Peralta to the damages liability of an individual official who lacks budgeting authority though not to prospective relief; no causation, particularly where the claimed injury is an increased risk rather than an event; qualified immunity for public employees, unavailable as a rule to private-firm employees (Richardson v. McKnight, AR-0961-C10; Roadmap 077); no policy or custom; the § 844.6 immunity and the narrow scope of § 845.6; independent-contractor status (Gov. Code § 810.2, AR-S506); exhaustion and limitations; and any bankruptcy stay, release or injunction only if an authenticated debtor schedule, applicable confirmed plan/order and the particular defendant, cause and relevant time period establish that defense (bankruptcy research lead; held roadmap numbering unresolved).

The deep companions to Roadmap 133 for these defenses are Playbooks 141 (constitutional medical-care defenses) and 138 (causation, damages and mitigation).

Causation#

Medication causation has two layers. The first is pharmacological: whether the gap or substitution changed the drug's effect in the body, shown by levels, symptoms and the drug's known behavior. The second is clinical: whether that change caused the event (the seizure, the hyperglycemic crisis, the psychiatric decompensation, the clot) and the injury that followed. Under Gordon the failure to take reasonable measures must have caused the injury; under Jett the plaintiff must show "harm caused by the indifference," though the harm need not be substantial. For chronic conditions such as HIV, the question whether an interruption caused physical injury, a medically demonstrable loss or only increased risk matters to particular compensatory-damages theories. 42 U.S.C. §1997e(e) restricts a prisoner's federal civil action for mental or emotional injury without a prior physical injury (or qualifying sexual act); it is not a universal bar to nominal, punitive or other non-emotional constitutional remedies. Jurisdictional and claim-specific authority and subsequent case history require counsel review. Expert pharmacology/clinical-causation evidence is often necessary, particularly for substitution effects, viral-load changes and multifactorial harms, but necessity depends on the claim and the complexity of facts; do not state a universal expert-testimony rule. The dose-by-dose table is a starting chronology, not proof of causation (subject-only crosslinks to evidence and causation roadmaps).

Damages and remedies#

Roadmap 096.2 states remedies by forum and Roadmap 076 addresses damages in custody medical cases. In outline: compensatory damages under §1983 and state law; ADA Title II damages are separately limited: the Ninth Circuit's published March 11, 2026 Payan v. LACCD opinion holds emotional-distress damages unavailable under Title II, while certain independently proven non-emotional losses may be compensable; this is not a ruling that a medication lapse necessarily qualifies as disability discrimination; the physical-injury limit for prisoner actions (AR-096-F04); professional-negligence noneconomic-damages limits (Civ. Code § 3333.2; AR-0961-S03); punitive damages against individuals and private entities under applicable standards (Civ. Code § 3294, AR-037-S01) but not against a public entity under state law (Gov. Code § 818, AR-S905; not opened) or a municipality under § 1983 (City of Newport v. Fact Concerts, AR-C73); survival and wrongful-death rules after a death (AR-065-S08, AR-0961-S06, AR-065-S07; Roadmap 065). Where a person remains in custody and a medication is being withheld, prospective relief is often the remedy that matters, and Peralta confirms that lack of resources is not a defense to it.

Discovery#

Roadmaps 084 and 038 address discovery methods. Medication discovery is document-heavy: the medication administration record in native electronic form with its audit trail (who entered each dose and when, and any later edits); order histories; pharmacy dispensing and delivery data; formulary versions; non-formulary request logs and decisions; interchange protocols; medication-error reports (subject to § 1157 where it applies); staffing for medication passes on the relevant dates; and custody movement logs. When procedurally available in filed litigation and subject to the governing discovery rules and objections, a properly noticed organization deposition (Code Civ. Proc. §2025.230; Fed. R. Civ. P. 30(b)(6), exact current text/source authentication pending) can designate subjects such as intake verification, formulary review and MAR reason codes; it is not an unconditional pre-suit right to enter systems or compel confidential material. Scope, timing, proportionality and protective orders remain litigable. A request for admission that a particular drug was in stock on a particular date can fix a contested point.

CFMG/Wellpath-specific relevance#

Why this may matter in a CFMG/Wellpath setting. In the public-record contractor model, a county contracts with a private firm for jail health services, and pharmacy services may be provided by the firm, by a subcontracted pharmacy vendor, or by the county (Roadmaps 003, 004). Which entity maintained the formulary, procured and dispensed drugs, employed the nurses who administered them, and approved non-formulary requests is a question of the contracts and their exhibits, which are public records subject to the Public Records Act's exemptions (AR-S801; Roadmaps 086, 087). Entity precision is essential. Inherited references to California Forensic Medical Group, Inc., Wellpath CFMG, Inc., the bankruptcy debtor list, case-number associations and injunctions remain research leads until primary filed schedules, court orders, plan terms and operative county/pharmacy contracts are authenticated. Neither a brand name nor a debtor surname identifies the employer, pharmacy, treating provider, legal obligor or plan beneficiary. Hold crosslinks to the 079–099 and 100–124 number ranges until source-body reconciliation, without treating the absence of 090–091 from an index as proof of a collision. Nothing here states that any entity withheld, substituted, missed or mis-documented any medication.

Primary authorities#

Related roadmaps#

003, 004, 007, 040, 041, 042, 043, 044, 045, 046, 047, 048, 049, 050, 054, 055, 057, 059, 060, 061, 062, 063, 065, 066, 068, 072, 074, 075, 076, 077, 078, 079–099 (all numeric destinations held pending source-body mapping, including 090/091), 100–124 (held; do not infer subjects from index), 096.2 (supplement number held for reconciliation), 131, 132, 133. Refer by subject until canonical source reconciliation completes.

Companion worksheet#

Companion work products should contain (1) a dose-by-dose medication reconciliation, (2) an order/substitution and formulary-change register, (3) a care-setting transfer/handoff log, (4) a pharmacy supply-versus-MAR comparison and (5) a symptom/outcome chronology. In the existing drafts these correspond to inherited worksheet references in the 100–124 held namespace, including the previously identified medication-administration worksheet; do not assign a canonical worksheet number or hyperlink until the source-body crosswalk resolves it. Keep one row per ordered administration opportunity with the order, expected date/time, actual MAR entry, reason, recorder, independent dispensing corroboration and clinical effect.

What this page cannot do#

It cannot judge whether any medication, dose, substitution or formulation was clinically appropriate for any person; that requires qualified clinical review. It cannot say what any facility's administration records, formulary or pharmacy logs contain, or whether any gap caused any injury. It does not compute any deadline, and it cannot decide whether a claim exists or against whom. It explains the law that governs medications in custody and the records that distinguish a clinical decision from a gap, so that those questions can be put to the documents, to clinicians and to counsel.